EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration

Nikhil Bommakanti, Benjamin K Young, Robert A Sisk, Audina M Berrocal, Jacque L Duncan, Benjamin Bakall, Marc T Mathias, Ishrat Ahmed, Sarah Chorfi, Jason Comander, Aaron Nagiel, Cagri G Besirli

Ophthalmology Retina · 2024-01 · 8 (1) · 42-48

DOI: 10.1016/j.oret.2023.08.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2024-01. Verfasst von Nikhil Bommakanti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Retinal Degeneration, Choroid Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, Biogen, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DegenerationChoroid DiseasesHumansRetrospective StudiesAtrophy

Stichwörter der Autor:innen

Chorioretinal atrophyGene therapyLeber congenital amaurosisLuxturnaVoretigene neparvovec-rzyl

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, Michigan.
  • Cincinnati Eye Institute, Cincinnati, Ohio; University of Cincinnati Department of Ophthalmology, Cincinnati, Ohio; Abrahamson Pediatric Eye Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Bascom Palmer Eye Institute, University of Miami, Miami, Florida.
  • Department of Ophthalmology, University of California, San Francisco, California.
  • Associated Retina Consultants, Phoenix, Arizona.
  • Department of Ophthalmology, University of Colorado Denver School of Medicine, Aurora, Colorado.

Förderung

  • NEI NIH HHS
  • Biogen
  • National Eye Institute
  • University of California, San Francisco
  • Foundation Fighting Blindness
  • E. Matilda Ziegler Foundation for the Blind
  • Knights Templar Eye Foundation
  • Applied Genetic Technologies Corporation

Zitieren

APA

Bommakanti, N., Young, B. K., Sisk, R. A., Berrocal, A. M., Duncan, J. L., Bakall, B., Mathias, M. T., Ahmed, I., Chorfi, S., Comander, J., Nagiel, A., & Besirli, C. G. (2024). Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration. Ophthalmology Retina, 8(1), 42-48. https://doi.org/10.1016/j.oret.2023.08.017

Vancouver

Bommakanti N, Young BK, Sisk RA, Berrocal AM, Duncan JL, Bakall B, et al. Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration. Ophthalmology Retina. 2024;8(1):42-48. doi:10.1016/j.oret.2023.08.017

BibTeX
@article{Bommakanti2024,
  author = {Bommakanti, Nikhil and Young, Benjamin K and Sisk, Robert A and Berrocal, Audina M and Duncan, Jacque L and Bakall, Benjamin and Mathias, Marc T and Ahmed, Ishrat and Chorfi, Sarah and Comander, Jason and Nagiel, Aaron and Besirli, Cagri G},
  title = {Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration},
  journal = {Ophthalmology Retina},
  year = {2024},
  volume = {8},
  number = {1},
  pages = {42--48},
  doi = {10.1016/j.oret.2023.08.017}
}
Kostenlos starten →